Newsletter


Point-of-care testing: state-of-the art and
perspectives
Point-of-care testing (POCT) is becoming an increasingly popular way to perform laboratory tests closer to the patient. This option has several recognized advantages, such as accessibility, portability, speed, convenience, ease of use, ever-growing test panels, lower cumulative healthcare costs when used within appropriate clinical pathways, better patient empowerment and engagement, and reduction of certain pre-analytical errors

Chemical Luminescence Immunity Analyzer Market by Application: Empowering Growth, Forecasted Value 94.96$ Bn by 2031
According to MRI, the Chemical Luminescence Immunity Analyzer market was valued at USD 52.22 billion in 2024. It is projected to grow at a compound annual growth rate (CAGR) of 10.49% during the forecast period, reaching an estimated USD 94.96 billion by 2031.
Chemical Luminescence Immunity Analyzer Market by Application: Through AI-Driven Solutions-2031: Anticipated Surge in Growth
The Chemical Luminescence Immunity Analyzer market is expected to experience substantial growth from 2024 to 2031, with a compound annual growth rate (CAGR) of 10.49%.

Lab Automation Market: Transforming Healthcare and Research
The lab automation market is experiencing rapid growth, driven by technological advancements and increasing demand for more efficient, accurate, and faster results across a wide range of industries. According to recent reports, the lab automation market is projected to reach USD 7.71 billion by 2029, up from USD 5.85 billion in 2024, growing at a CAGR of 6.9% during the forecast period. This growth is primarily fueled by advancements in robotics, artificial intelligence (AI), and high-throughput screening technologies, all of which are transforming clinical research, diagnostics, and drug discovery.